Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-062854
Filing Date
2010-06-30
Accepted
2010-06-30 17:17:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 c03026e425.htm 425 106389
2 GRAPHIC c03026c0302600.gif GRAPHIC 3323
  Complete submission text file 0000950123-10-062854.txt   113228
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filed by) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis BioScience, Inc. (Subject) CIK: 0001409012 (see all company filings)

EIN.: 300431735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33657 | Film No.: 10927948
SIC: 2834 Pharmaceutical Preparations